- Facing pharmacy trends for the remainder of the year
- Senate passes Drug Quality and Security Act
- On the heels of Q3, Walgreens outlines shift in front-end strategy and pharmacy tailwinds looking forward
- New Rite Aid group VP pharmacy initiatives and clinical services to oversee Wellness Ambassador program
- Kathleen Sebelius cites pharmacists' importance as Rite Aid CEO introduces Obamacare resource program
WILMINGTON, Del. Anglo-Swedish drug maker AstraZeneca has settled 17,500 product liability cases involving one of its drugs, AstraZeneca said Monday.
The drug maker announced that it would pay $198 million to users of the psychiatric drug Seroquel (quetiapine fumarate) who had alleged it caused them to develop diabetes.
In addition, 2,900 of the cases were dismissed, and AstraZeneca won the one case that has so far gone to jury trial.